User:MDolinar: Difference between revisions
No edit summary |
mNo edit summary |
||
Line 2: | Line 2: | ||
I am the Biochemistry Chair at the [http://www.uni-lj.si/ University of Ljubljana] (Slovenia) [http://www.fkkt.uni-lj.si/en/ Faculty of Chemistry and Chemical Technology]. Before joining the Faculty (in 2001), I was research associate at the [http://www.ijs.si/ijsw/JSI Jozef Stefan Institute] where my research was focused on cysteine proteinases (mainly cathepsins L, H). As part-timer at the JSI from 2001-2006, I continued my work on cathepsins but spent much of my time organizing research conferences on proteinases and their inhibitors. | I am the Biochemistry Chair at the [http://www.uni-lj.si/ University of Ljubljana] (Slovenia) [http://www.fkkt.uni-lj.si/en/ Faculty of Chemistry and Chemical Technology]. Before joining the Faculty (in 2001), I was research associate at the [http://www.ijs.si/ijsw/JSI Jozef Stefan Institute] where my research was focused on cysteine proteinases (mainly cathepsins L, H). As part-timer at the JSI from 2001-2006, I continued my work on cathepsins but spent much of my time organizing research conferences on proteinases and their inhibitors. | ||
Currently, I am trying to establish new research cooperations (we are planning to prepare recombinant humanized antibodies together with a group at the | Currently, I am trying to establish new research cooperations (we are planning to prepare recombinant humanized antibodies together with a group at the Blood Transfusion Centre of Slovenia) and start a new project on allergens. In 2006 I am co-supervisor of the (first ever) [http://bio.ijs.si/iGEM/iGEM-SI-2006e.html Slovenian iGEM team]. |
Revision as of 01:22, 30 March 2006
Marko Dolinar
I am the Biochemistry Chair at the University of Ljubljana (Slovenia) Faculty of Chemistry and Chemical Technology. Before joining the Faculty (in 2001), I was research associate at the Jozef Stefan Institute where my research was focused on cysteine proteinases (mainly cathepsins L, H). As part-timer at the JSI from 2001-2006, I continued my work on cathepsins but spent much of my time organizing research conferences on proteinases and their inhibitors.
Currently, I am trying to establish new research cooperations (we are planning to prepare recombinant humanized antibodies together with a group at the Blood Transfusion Centre of Slovenia) and start a new project on allergens. In 2006 I am co-supervisor of the (first ever) Slovenian iGEM team.